Global upregulation of gene expression associated with renal dysfunction in DOCA-salt-induced hypertensive rats occurs via signaling cascades involving epidermal growth factor receptor: a microarray analysis
- PMID: 19410658
- DOI: 10.1016/j.vph.2009.04.004
Global upregulation of gene expression associated with renal dysfunction in DOCA-salt-induced hypertensive rats occurs via signaling cascades involving epidermal growth factor receptor: a microarray analysis
Abstract
Renal dysfunction is a major cause of morbidity and mortality in patients with hypertension. In an attempt to understand the molecular mechanisms leading to renal dysfunction and in particular that of epidermal growth factor receptor (EGFR) and RasGTPase signaling, we analyzed global gene expression changes in the kidneys of deoxycorticosterone acetate (DOCA)-salt-induced hypertensive rats with and without treatment with AG1478, a selective inhibitor of EGFR tyrosine kinase, or FPTIII, a farnesyl transferase inhibitor known to inhibit RasGTPase. Microarray-based global gene expression analysis was performed in triplicate for each rat kidney taken from normotensive Wistar rats, DOCA-salt hypertensive (DH) rats, DH rats treated with AG1478, or DH rats treated with FPTIII. From the initial data set of 10,163 gene spots per group, upregulation of 2398 genes and downregulation of only 50 genes by more than 2-fold was observed in hypertensive rat kidneys compared to non-diseased controls. Interestingly, treatment of animals with AG1478 or FPTIII prevented upregulation of more than 97% of genes associated with hypertension in the rat kidney. Analysis of proteinuria, renal artery responsiveness and histopathology studies confirmed that DOCA-salt hypertensive rats had developed kidney damage over the study period and that this kidney dysfunction could be significantly prevented upon AG1478 or FPTIII treatment without normalising blood pressure. Taken together, our data imply that signaling cascades involving EGFR and/or RasGTPase pathways are key contributors to the induction of renal damage in hypertension and these and potentially other downstream effector molecules may serve as novel targets for therapeutic intervention.
Similar articles
-
Early inhibition of EGFR signaling prevents diabetes-induced up-regulation of multiple gene pathways in the mesenteric vasculature.Vascul Pharmacol. 2009 Oct;51(4):236-45. doi: 10.1016/j.vph.2009.06.008. Epub 2009 Jul 2. Vascul Pharmacol. 2009. PMID: 19577003
-
L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.Hypertens Res. 2011 Apr;34(4):521-9. doi: 10.1038/hr.2010.279. Epub 2011 Jan 27. Hypertens Res. 2011. PMID: 21270815
-
Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats.J Physiol Pharmacol. 2006 Sep;57(3):343-57. J Physiol Pharmacol. 2006. PMID: 17033089
-
Aldosterone as a renal growth factor.Steroids. 2010 Aug-Sep;75(8-9):550-4. doi: 10.1016/j.steroids.2009.09.008. Epub 2009 Sep 24. Steroids. 2010. PMID: 19782095 Review.
-
Angiogenesis inhibitor therapies: focus on kidney toxicity and hypertension.Am J Kidney Dis. 2007 Aug;50(2):203-18. doi: 10.1053/j.ajkd.2007.04.025. Am J Kidney Dis. 2007. PMID: 17660022 Review.
Cited by
-
Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies.Front Pharmacol. 2024 Aug 21;15:1394997. doi: 10.3389/fphar.2024.1394997. eCollection 2024. Front Pharmacol. 2024. PMID: 39234105 Free PMC article. Review.
-
The endoplasmic reticulum stress and the unfolded protein response in kidney disease: Implications for vascular growth factors.J Cell Mol Med. 2020 Nov;24(22):12910-12919. doi: 10.1111/jcmm.15999. Epub 2020 Oct 16. J Cell Mol Med. 2020. PMID: 33067928 Free PMC article. Review.
-
Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis.Nat Commun. 2019 Apr 23;10(1):1847. doi: 10.1038/s41467-019-09861-z. Nat Commun. 2019. PMID: 31015462 Free PMC article.
-
Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.Pharmacol Res. 2019 Mar;141:32-45. doi: 10.1016/j.phrs.2018.12.009. Epub 2018 Dec 13. Pharmacol Res. 2019. PMID: 30553823 Free PMC article. Review.
-
Case of Proteinuria, Worsening Hypertension, and Glomerular Endotheliosis With Erlotinib and Gefitinib.Kidney Int Rep. 2018 Jul 10;3(6):1477-1481. doi: 10.1016/j.ekir.2018.07.005. eCollection 2018 Nov. Kidney Int Rep. 2018. PMID: 30450475 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous